Search

everythinglearnresearchcommunity

for

Search:↓

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Female hair loss linked to metabolic syndrome, not in males.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Women's hair grows faster and thicker than men's, but hair growth slows for both genders with pattern hair loss.

Men and premenopausal women in Korea show different patterns in iron and vitamin D levels, with no clear pattern for postmenopausal women.

Gender differences affect allergy prevalence, severity, and response to environmental toxins, with women often more affected than men.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Women pay more for the same 5% minoxidil foam than men, but prices for liquid solutions are similar.

Men are more likely to have larger basal cell carcinomas and squamous cell carcinomas, while women have more superficial basal cell carcinomas and tumors on their legs and central face.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Women with pancreatic cancer are more likely to have certain side effects from chemotherapy than men.

Women who lost hair from childhood head radiation are more likely to face mental health issues than men.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

Women's facial moisturizers cost more per ounce than men's.

Gender affects wool traits in sheep, with males and females showing differences in skin proteins related to wool growth.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

Feminizing hormone therapy increases kidney filtration rate.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Hair transplantation is important for transgender patients to enhance their masculine or feminine appearance.

The conclusion is that recognizing the difference between gender identity and biological sex is crucial in dermatology to improve patient care and research accuracy.